Current Advances in Nanopharmaceuticals

Ozturk-Atar K., EROĞLU H., GÜRSOY R. N., ÇALIŞ S.

JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, vol.19, no.7, pp.3686-3705, 2019 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Review
  • Volume: 19 Issue: 7
  • Publication Date: 2019
  • Doi Number: 10.1166/jnn.2019.16764
  • Journal Name: JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
  • Page Numbers: pp.3686-3705
  • Keywords: Nanopharmaceuticals, Regulatory Challenges, Nano Targeting, Market Status, Nanosafety, DRUG-DELIVERY, BIOMEDICAL APPLICATIONS, RISK-ASSESSMENT, NANOPARTICLE, NANOMEDICINE, CHALLENGES, BIODISTRIBUTION, NANOMATERIALS, THERAPEUTICS, FORMULATION
  • Hacettepe University Affiliated: Yes

Abstract

Nanotechnology is one of the hot topics not only in pharmaceutical industry, but also in many others that are currently existing in our daily lives. Since the last two decades, many nanotechnology based drugs have been introduced in the market providing new and optimized treatment perspectives. In addition to that, local regulatory authorities also meet new challenging issues regarding the development process of the nanopharmaceuticals. It is a clear fact that the novelty of nanopharmaceuticals also include a more precise clarification process on the efficacy and safety of the formulations for the benefit of public health. Therefore, current scientific improvements as well as current regulatory perspectives are reflected in this review.